Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.

Luboshitzky, Rafael; Herer, Paula; Shen-Orr, Zila

Luboshitzky, Rafael; Herer, Paula; Shen-Orr, Zila.

Affiliation

Luboshitzky R; Endocrine Institute, Haemek Medical Center, Afula 18101, Israel. luboshitzky_r@clalit.org.il.

Neuro Endocrinol Lett ; 23(4): 309-13, 2002 Aug.

Article in En | MEDLINE | ID: mdl-12195232

Subject(s)

Androgen Antagonists/administration & dosage; Cyproterone Acetate/administration & dosage; Estradiol Congeners/administration & dosage; Ethinyl Estradiol/administration & dosage; Hyperandrogenism/drug therapy; Melatonin/analogs & derivatives; Melatonin/urine; Adolescent; Adrenocortical Hyperfunction/drug therapy; Adrenocortical Hyperfunction/urine; Adult; Drug Therapy, Combination; Female; Humans; Hyperandrogenism/urine; Melatonin/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cyproterone Acetate / Hyperandrogenism / Estradiol Congeners / Ethinyl Estradiol / Androgen Antagonists / Melatonin Limits: Adolescent / Adult / Female / Humans Language: En Journal: Neuro Endocrinol Lett Year: 2002 Document type: Article Affiliation country: Israel Country of publication: Sweden

Search on Google

Add to My VHL

XML

PubMed Links